Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (17)

2024

  1. Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients

    Frontiers in Pharmacology, Vol. 15

2023

  1. Protein Plasma Levels of the IGF Signalling System Are Altered in Major Depressive Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 20

2022

  1. Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients

    Frontiers in Pharmacology, Vol. 13

  2. New Trends in Cognitive Aging and Mild Cognitive Impairment

    Geriatrics (Switzerland)

2021

  1. Relationship between sleep quality and cognitive performance in patients with epilepsy

    Epilepsy and Behavior, Vol. 122

  2. Voices 2: Improving Prosodic Recognition in Schizophrenia With an Online Rehabilitation Program

    Frontiers in Psychology, Vol. 12

2020

  1. Efectividad del programa de intervención «El Trisquel» en personas con trastornos del espectro de la esquizofrenia

    Actas Espanolas de Psiquiatria, Vol. 48, Núm. 5, pp. 209-219

  2. Plasma β-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Editorial: Novel approaches to the neuropharmacology of mood disorders

    Frontiers in Pharmacology

  2. Improving emotion recognition in schizophrenia with “VOICES”: An on-line prosodic self-training

    PLoS ONE, Vol. 14, Núm. 1

  3. Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways

    Frontiers in Psychiatry, Vol. 10

2018

  1. Genome wide analysis of rare copy number variations in alcohol abuse or dependence

    Journal of Psychiatric Research, Vol. 103, pp. 212-218

2015

  1. Experiencia clínica con lacosamida en Galicia: Estudio GALACO

    Revista de Neurologia, Vol. 61, Núm. 12, pp. 536-542

2014

  1. Serotonin 2A receptor clustering in peripheral lymphocytes is altered in major depression and may be a biomarker of therapeutic efficacy

    Journal of Affective Disorders, Vol. 163, pp. 47-55

2012

  1. Serotonin transporter clustering in blood lymphocytes as a putative biomarker of therapeutic efficacy in major depressive disorder

    Journal of Affective Disorders, Vol. 137, Núm. 1-3, pp. 46-55

2011

  1. Hyperphagia and central mechanisms for leptin resistance during pregnancy

    Endocrinology, Vol. 152, Núm. 4, pp. 1355-1365

2004

  1. Diferencias clínicas en la depresión según la clase social

    Anales de Psiquiatria, Vol. 20, Núm. 10, pp. 413-421